We are live on ! Find out more
TRAW icon

Traws Pharma
TRAW

13 hedge funds and large institutions have $1.36M invested in Traws Pharma in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more funds holding

Funds holding: 9 → 13 (+4)

10% less capital invested

Capital invested by funds: $1.51M → $1.36M (-$153K)

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$148K
2
ARTA
A.R.T. Advisors
New York
+$74.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$74.1K
4
DCLA
Douglas C. Lane & Associates
New York
+$74.1K
5
UBS Group
UBS Group
Switzerland
+$74.1K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$10K
2
DA
Dunvegan Associates
California
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$303K +$74.1K +1 +20%
WMSA
2
Weiss Multi-Strategy Advisers
New York
$254K +$74.1K +1 +25%
Renaissance Technologies
3
Renaissance Technologies
New York
$144K +$148K +2 +200%
Citigroup
4
Citigroup
New York
$134K – – –
DCLA
5
Douglas C. Lane & Associates
New York
$67K +$74.1K +1 New
Jacobs Levy Equity Management
6
Jacobs Levy Equity Management
New Jersey
$65K – – –
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$47K – – –
UBS Group
8
UBS Group
Switzerland
$47K +$74.1K +1 New
Citadel Advisors
9
Citadel Advisors
Florida
$46K +$74.1K +1 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$44K – – –
BFA
11
BlackRock Fund Advisors
California
$35K – – –
VKH
12
Virtu KCG Holdings
New York
$34K – – –
ARTA
13
A.R.T. Advisors
New York
$28K +$74.1K +1 New
HK
14
Horizon Kinetics
New York
$23K – – –
Creative Planning
15
Creative Planning
Kansas
$22K – – –
Goldman Sachs
16
Goldman Sachs
New York
$17K – – –
HighTower Advisors
17
HighTower Advisors
Illinois
$17K – – –
Northern Trust
18
Northern Trust
Illinois
$17K – – –
BCM
19
Bridgeway Capital Management
Texas
$11K – – –
BIM
20
BlackRock Investment Management
Delaware
$2K – – –
Deutsche Bank
21
Deutsche Bank
Germany
$1K – – –
TRCT
22
Tower Research Capital (TRC)
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
Bank of America
24
Bank of America
North Carolina
– -$10K – –
DA
25
Dunvegan Associates
California
– -$1K – –

TRAW Hedge Fund Activity: Q4 2015 in Review

13 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q4 2015, worth a combined $1.36M — down 10% from $1.51M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TRAW positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $148K. The largest seller was Bank of America, cutting an estimated $10K.

  • 13 institutional investors held Traws Pharma (TRAW) as of Q4 2015, up from 9 in Q3 2015.
  • Funds reported $1.36M of Traws Pharma stock for Q4 2015, down 10% quarter-over-quarter.
  • 4 funds opened new Traws Pharma positions in Q4 2015 and 0 closed out, a net change of +4 holders.
  • The largest Traws Pharma buyer in Q4 2015 was Renaissance Technologies, an estimated $148K added.
  • The largest Traws Pharma seller in Q4 2015 was Bank of America, an estimated $10K sold.

Based on aggregated 13F filings for Q4 2015.